Injective climbs today: Key reasons behind the rally

Traders Union
All News
Crypto News
Injective surges 10.82% to $3.38 today

Highlights

The Injective community approved the IIP-619 mainnet upgrade, enhancing real-time Ethereum Virtual Machine architecture and expanding next-generation payment capabilities.
Upbit temporarily suspended INJ deposits and withdrawals following the 'Volan' network upgrade, while Injective completed its 226th Community Buyback program to reduce supply.
INJ trades at $3.38 with short-term support at the MA-20 ($3.28), strong resistance at $3.63, and persistent medium- to long-term weakness below the MA-50 ($4.26) and MA-200 ($8.33).

Network upgrades drive positive sentiment amid temporary exchange freeze

The Injective community approved the IIP-619 mainnet upgrade proposal, enhancing the platform's real-time Ethereum Virtual Machine architecture and broadening next-generation payment support. Secondary to this, the 'Volan' network upgrade prompted Upbit to temporarily suspend INJ deposits and withdrawals as a standard measure. Injective also completed its 226th Community Buyback program round, continuing its supply reduction efforts.

Anton Kharitonov, expert at Traders Union, identifies a fragile technical setup for Injective. He notes that INJ price is propped up by short-term momentum but faces persistent resistance from higher moving averages. Weakness in daily indicators and overwhelming selling pressure reflect clear downside risks. Recent community upgrades and continued supply reduction efforts are unlikely to offset the dominant negative sentiment in the near term. "Unless price reclaims critical resistance above $3.63, any bounce should be viewed with skepticism and defensive positioning maintained."

Viktoras Karapetjanc, expert at Traders Union, sees structural progress in Injective’s ecosystem. He highlights the positive community-driven upgrades and ongoing buybacks as supportive fundamentals. In his view, the evolving EVM architecture and proactive supply management reinforce Injective’s long-term viability despite current market volatility. Bullish structure remains intact as the project continues to deliver on its roadmap. "I remain optimistic that Injective’s network developments and flexible payment initiatives can catalyze further growth opportunities ahead."

Parshwa Turakhiya, analyst, emphasizes the clash between oversold signals and surging intraday momentum. He sees the strong ADX and gap-driven price spike as evidence of growing speculative interest, even as daily oscillators urge caution. With near-term volatility high and support at $3.28 holding for now, short-term rebound trades could emerge if buyers sustain control above immediate resistance. "This is a market primed for fast, sentiment-driven setups — nimble traders should watch the $3.63 level closely for potential breakouts."

Divergent momentum as intraday strength clashes with broader weakness

Momentum readings are mixed: the MACD signals strong selling, but ADX at 41.93 suggests a strong trend is present. RSI at 31.93, CCI at –78.26, and Stoch RSI near 61 indicate the market is oversold or nearing oversold, though Stoch RSI on lower timeframes is briefly overbought. BBP remains negative, confirming that sellers still dominate the intraday action. After a minor gap down at the open, INJ surged 10.82% to $3.38, with price finishing closer to today’s high of $3.79, highlighting high intraday volatility and pronounced strength toward highs. Intraday momentum and price action are at odds with daily momentum oscillators, reflecting a clear divergence between short-term buying and broader selling pressure.

Last time, analysts noted that Injective was stabilizing just above its short-term moving average but remained under persistent bearish pressure from medium- and long-term averages, with negative momentum confirmed by daily MACD, ADX, and an RSI near oversold levels. Immediate resistance is seen at $3.63 with support near the 20-day moving average, and short-term price action is expected to remain range-bound with limited rebound potential.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.